Advertisement
Screener

Intersect ENT, Inc. Forms 3, 4 and 5: Other

Intersect ENT, Inc. Forms 3, 4 and 5: Other

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 4 rows, 4 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2017-08-03: Reporting owner Kline Teresa L.; Form 3; Security No securities beneficially owned; Transaction Holding.
  • 2017-07-31: Reporting owner Parker Drake R.; Form 3; Security No securities beneficially owned.; Transaction Holding.
  • 2014-10-02: Reporting owner Fletcher Mark J; Form 3/A; Security No securities beneficially owned.; Transaction Holding.
  • 2014-10-02: Reporting owner Fletcher Mark J; Form 4/A; Security No securities beneficially owned.; Transaction Holding.
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2017-08-03
holding as of filing
Kline Teresa L.
Director
3No securities beneficially owned
Non-derivative · Direct
Holding
0 owned after
no price filed2017-08-03
2017-07-31
holding as of filing
Parker Drake R.
Officer (Chief Business Officer)
3No securities beneficially owned.
Non-derivative · Direct
Holding
0 owned after
no price filed2017-07-31
2014-10-02
holding as of filing
Fletcher Mark J
Director
3/ANo securities beneficially owned.
Non-derivative · Direct
Holding
0 owned after
no price filed2014-10-02
2014-10-02
holding as of filing
Fletcher Mark J
Director
4/ANo securities beneficially owned.
Non-derivative · Direct
Holding
0 owned after
no price filed2014-10-02